Clinical evaluation of efficacy of Alambushadi Ghana Vati and Vaitarana Basti in the management of Amavata with special reference to rheumatoid arthritis.Ayu. 2016 Apr-Jun; 37(2):105-112.AYU
The clinical presentation of Amavata closely mimics with the special variety of rheumatologic disorders called rheumatoid arthritis (RA). The Ayurvedic approach toward the treatment of Amavata is the need of present era as no system is successful in providing the complete cure to this disease. Amavata is a challenging and a burning problem of medical science. Prevalence of RA is approximately 0.8% of the population. Due to wide spectrum of disease, much prevalence in the society, and lack of effective medicine, the disease had been chosen for the study. The aim of the research was to study the efficacy of Alambushadi Ghana Vati and Vaitarana Basti in the management of Amavata (RA). It was a single-center, randomized, open-clinical study. In the present study, 30 clinically diagnosed patients of Amavata were selected and randomly divided into two groups by lottery method. Alambushadi Ghana Vati was given in dose of two tablets (each 500 mg) three times in a day with lukewarm water after meal for 30 days, while Vaitarana Basti on alternate day (15 Basti) had been given simultaneously in the second group along with drug of first group. Statistical analysis was done using InStat GraphPad 3 Software. Wilcoxon matched pairs signed ranks test was used for the analysis of nonparametric data, while paired t-test was used for parametric data analysis and Mann-Whitney test and unpaired t-test were used for intergroup comparison. Statistically highly significant (HS) improvement was found in erythrocyte sedimentation rate, and HS results were found in symptoms of Amavata when the Vaitarana Basti was used along with Alambushadi Ghana Vati. With excellent relief in 20% patients, significant relief in 60% patients, moderate relief in 13.33% patients, whereas mild relief in 6.66% patients. On comparing the effect of two therapies, it can be concluded that Group B (Alambushadi Ghana Vati and Vaitarana Basti) provided better relief than Group A (Alambushadi Ghana Vati) in most of the sign and symptom of the disease at significant level.